8 Spiering BA, Kraemer WJ, Hatfield DL, et al
It also inhibits microglial activation in the brain and spinal cord, reducing production of reactive oxygen species and potentially neuroexcitatory chemicals
The company said it will leverage low-cost oral medications from Cost Plus Drugs as an option to treat obesity within a clinically validated prescribing protocol, while offering a complete, cost-efficient solution to employers seeking to expand coverage for weight management and chronic co-conditions like diabetes, high cholesterol, and hypertension. Cost Plus Drugs will provide low-cost oral obesity medications, according to the companies
Unlike many other weight loss therapies, tirzepatide targets both GLP-1 and GIP receptors, enhancing its effectiveness in reducing appetite and increasing satiety
GLP-1s Are Only Part of the Story GLP-1 medications often receive the headlines, but theyre only one part of an organizations overall healthcare strategy
Early research shows tirzepatide may even reduce alcohol cravings for certain individuals